Actor Shazahn Padamsee married businessman Ashish Kanakia on June 5, and their union is shaping up to be both a deeply personal and grand artistic affair. While traditional rituals like the haldi and sangeet are part of the celebrations, the couple has curated a Broadway-inspired evening as a tribute to Shazahn’s illustrious theatrical lineage. Drawing from the legacy of her late father, Padma Shri Alyque Padamsee, the event will feature live musical performances by theatre veterans and close family.

In a strategic move to diversify their storytelling portfolio, AAZ Films and Bhanushali Studios have launched their first co-produced feature, Parivarik ManuRanjan, under a new three-film collaboration. Headlined by acclaimed actor Pankaj Tripathi and the versatile Aditi Rao Hydari, the film promises to deliver a heartwarming yet humorous take on family dynamics through an unlikely pairing. Helmed by director Varun V. Sharma, the film commenced principal photography in Lucknow on June 5, 2025.

Indian actor and producer Rana Daggubati has offered a nuanced take on the recent backlash faced by legendary actor Kamal Haasan over his remarks about the Kannada language. The controversy erupted in the lead-up to Haasan’s upcoming film Thug Life, sparking a wave of online criticism. Speaking in a recent interview, Daggubati addressed the growing culture of instant judgment and hypersensitivity on social media.

Coal India Ltd (CIL), the country’s largest coal producer and a state-owned Maharatna enterprise, has entered into a strategic memorandum of understanding (MoU) with Indian Port Rail & Ropeway Corporation Ltd (IPRCL) to advance its rail infrastructure capabilities. The agreement, though non-binding, signals a concerted effort to streamline coal evacuation and improve logistics efficiency across CIL and its subsidiaries.

The Indian Renewable Energy Development Agency Ltd (IREDA), a key public sector financier under the Ministry of New and Renewable Energy, has initiated a Qualified Institutional Placement (QIP) to raise Rs. 5,000 crore. The company’s board has set a floor price of Rs. 173.83 per equity share, in accordance with SEBI’s pricing norms. The QIP, approved by both the board and shareholders earlier this year, seeks to strengthen IREDA’s capital base in response to rising demand for renewable energy financing.

India is signaling a robust shift in its international trade and investment diplomacy by proposing dedicated industrial enclaves for Italian businesses. Commerce and Industry Minister Piyush Goyal, during a high-level business forum in Italy, extended a strategic invitation to Italian firms to establish manufacturing hubs within India’s expanding industrial corridors. This initiative, backed by a Rs.

Aditya Birla Group has marked a significant milestone in its global growth strategy by acquiring Cargill’s specialty chemical manufacturing facility in Dalton, Georgia. Executed through its U.S. subsidiary, Aditya Birla Chemicals (USA) Inc., the acquisition strengthens the Group’s Advanced Materials business and expands its footprint in the American manufacturing sector.

In a decisive move to stimulate a slowing economy and support credit growth, the Reserve Bank of India (RBI) has slashed the Cash Reserve Ratio (CRR) by 100 basis points and the repo rate by an unexpected 50 basis points. The CRR cut, to be implemented in tranches, is expected to inject Rs. 2.5 lakh crore into the banking system by the end of 2025, while the lower repo rate eases borrowing costs. These measures aim to spur economic activity, improve monetary transmission, and stabilize market sentiment.

The monsoon season brings with it a myriad of health challenges, primarily due to the environmental factors such as high humidity, stagnant water, and poor sanitation. These conditions create an ideal breeding ground for infections, including mosquito-borne diseases like dengue and malaria, as well as waterborne illnesses like cholera and typhoid. Fungal and respiratory infections also become more prevalent due to dampness. This article outlines ten practical and preventive measures to protect yourself and your family from infections during the rainy season.

Dr. Reddy’s Laboratories has entered a strategic collaboration with international biotech firm Alvotech to co-develop and commercialize a biosimilar candidate targeting Keytruda (pembrolizumab), a leading immuno-oncology drug with global sales exceeding USD 29.5 billion in 2024. This partnership leverages the combined expertise of both companies in biosimilar innovation, aiming to expedite product development and broaden market access worldwide. The agreement entails joint responsibility for development, manufacturing, and cost-sharing, positioning Dr.